Neuroscience, Inc.
United StatesFDA applicant, unverified
- Devices
- 4
What Neuroscience, Inc. makes
Neuroscience, Inc. manufactures neurodiagnostic devices, including the NEUROMAPPER 1620 for nerve conduction studies, a somatosensory evoked potential stimulator for neurological assessments, and EEG mapping systems like the MAP-10. The company also provides software solutions, such as ISTAT, for clinical data processing and analysis in neurophysiology.
The portfolio includes devices classified as Class I and Class II under FDA regulations, with submissions recorded in the 510(k) clearance pathway. The company is based in the United States.
Catalogue
Neuromapper 1620 Ref K870263
Regimes: 510(k) Registry: 510(k)Somatosensory Evoked Potential Stimulator Ref K855232
Regimes: 510(k) Registry: 510(k)Neuroscience Map-10 Eeg Ref K850430
Regimes: 510(k) Registry: 510(k)Istat Software Ref K871931
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Neuroscience, Inc. have in the registry?
The registry currently lists 4 devices for Neuroscience, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Neuroscience, Inc.'s devices?
Among its 4 most recently registered devices, Neuroscience, Inc. has devices listed in FDA 510(k) (4 devices).
What risk classes do Neuroscience, Inc.'s devices fall under?
Among its 4 most recently registered devices, the classes recorded for Neuroscience, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Neuroscience, Inc. in the registry?
The most recently registered devices listed for Neuroscience, Inc. include NEUROMAPPER 1620, SOMATOSENSORY EVOKED POTENTIAL STIMULATOR, NEUROSCIENCE MAP-10 EEG and ISTAT SOFTWARE.